Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Mesoblast Ltd banner

Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 2.46 AUD -4.28% Market Closed
Market Cap: AU$3.2B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+19%
5Y
+7%
10Y
-
Liabilities
+
3Y
+13%
5Y
+2%
10Y
-
Equity
+
3Y
+20%
5Y
+9%
10Y
-

Balance Sheet Decomposition
Mesoblast Ltd

Balance Sheet
Mesoblast Ltd

Rotate your device to view
Balance Sheet
Currency: USD
Jun-2005 Jun-2006 Jun-2007 Jun-2008 Jun-2009 Jun-2010 Jun-2011 Jun-2012 Jun-2013 Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023 Jun-2024 Jun-2025
Assets
Cash & Cash Equivalents
12
6
10
5
1
6
4
4
288
185
111
81
45
37
50
129
136
60
71
63
161
Cash
0
0
0
1
0
0
3
3
7
4
21
22
8
37
50
129
136
60
71
63
161
Cash Equivalents
12
6
10
4
1
6
1
1
281
182
90
59
38
0
0
0
0
0
0
0
0
Short-Term Investments
0
0
0
9
12
22
278
208
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
0
2
11
11
6
4
4
3
50
4
2
5
4
7
3
15
Accounts Receivables
0
0
0
0
0
0
0
2
0
0
0
1
1
7
2
1
2
2
2
1
14
Other Receivables
0
0
0
0
0
0
2
9
11
6
4
3
3
43
2
1
3
2
5
2
1
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
Other Current Assets
0
0
0
0
0
0
0
0
4
1
8
4
15
13
8
6
7
5
4
21
6
Total Current Assets
12
6
11
14
14
28
285
223
303
192
122
89
64
101
63
137
148
70
82
86
204
PP&E Net
0
0
0
0
0
0
1
2
3
4
4
3
2
1
1
10
12
10
6
4
6
PP&E Gross
0
0
0
0
0
0
1
2
3
4
0
3
2
1
1
10
12
10
6
4
6
Accumulated Depreciation
0
0
0
0
0
0
0
1
1
2
0
5
7
8
8
10
15
18
22
20
18
Intangible Assets
1
1
1
1
0
0
392
390
384
516
516
453
452
450
449
447
446
444
443
441
437
Goodwill
0
0
0
0
0
0
118
119
117
133
134
134
134
134
134
134
134
134
134
134
134
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
Long-Term Investments
4
6
7
12
8
5
0
0
0
0
2
2
2
2
2
2
2
2
2
1
1
Other Long-Term Assets
0
0
0
0
0
0
23
4
1
3
2
2
2
2
2
2
2
2
2
2
1
Other Assets
0
0
0
0
0
0
118
119
117
133
134
134
134
134
134
134
134
134
134
134
134
Total Assets
16
N/A
12
-25%
18
+48%
27
+48%
22
-18%
33
+52%
818
+2 364%
737
-10%
807
+10%
848
+5%
782
-8%
684
-13%
656
-4%
692
+6%
652
-6%
734
+12%
745
+2%
662
-11%
669
+1%
669
0%
785
+17%
Liabilities
Accounts Payable
0
2
0
1
1
1
3
12
19
20
28
27
22
19
13
25
20
23
20
7
19
Accrued Liabilities
0
0
0
0
0
0
1
0
1
5
0
2
4
4
4
6
4
3
2
7
6
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
36
56
8
10
16
57
Other Current Liabilities
2
2
0
0
0
0
29
33
27
16
20
0
11
1
13
23
15
17
10
42
20
Total Current Liabilities
2
3
1
2
1
1
33
46
46
40
48
29
37
24
44
90
94
51
42
73
103
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
59
67
63
50
99
106
102
71
Deferred Income Tax
0
0
0
0
0
0
137
136
133
150
149
63
49
20
11
1
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
95
66
52
119
116
64
53
43
48
30
20
15
19
13
13
Total Liabilities
2
N/A
3
+94%
1
-82%
2
+150%
1
-33%
1
+30%
265
+20 292%
247
-7%
232
-6%
309
+33%
314
+2%
156
-50%
139
-11%
146
+5%
171
+17%
184
+8%
163
-11%
165
+1%
168
+2%
189
+13%
187
-1%
Equity
Common Stock
16
15
32
49
50
74
511
496
598
639
709
770
830
889
910
1 051
1 163
1 165
1 249
1 311
1 509
Retained Earnings
1
7
14
25
30
42
65
1
45
116
203
203
275
304
390
463
542
628
706
789
871
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40
1
1
1
1
Other Equity
0
0
0
1
0
0
24
8
22
17
38
39
38
39
39
38
0
40
40
40
39
Total Equity
15
N/A
9
-39%
17
+96%
25
+44%
21
-17%
32
+53%
553
+1 638%
490
-11%
576
+18%
539
-6%
468
-13%
528
+13%
517
-2%
546
+6%
481
-12%
549
+14%
581
+6%
497
-15%
502
+1%
480
-4%
597
+24%
Total Liabilities & Equity
16
N/A
12
-25%
18
+48%
27
+48%
22
-18%
33
+52%
818
+2 364%
737
-10%
807
+10%
848
+5%
782
-8%
684
-13%
656
-4%
692
+6%
652
-6%
734
+12%
745
+2%
662
-11%
669
+1%
669
0%
785
+17%
Shares Outstanding
Common Shares Outstanding
95
95
109
121
138
156
283
289
316
320
337
382
429
479
495
580
683
685
858
1 141
1 280

See Also

Summary
MSB intrinsic value, competitors valuation, and company profile.
DCF Valuation
MSB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MSB stock valuation using valuation multiples.
Wall Street Estimates
MSB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MSB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.